Full Text View
Tabular View
No Study Results Posted
Related Studies
The Impact of Reducing Inflammation on Vascular Function in the Metabolic Syndrome
This study has been completed.
Study NCT00762827   Information provided by Brigham and Women's Hospital

First Received on September 26, 2008.   Last Updated on June 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolic Syndrome
Additional conditions recognized in this trial
Inflammation
Metabolic Syndrome X
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Pathologic Processes
Interventions listed in this trial
Salsalate
Placebo
Additional drug interventions recognized in this trial
Salicylsalicylic acid
Sodium Salicylate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Brigham and Women's Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services